5 completed, 1 unknown. 6 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Completed 5, Unknown 1 |
| Phase 2 | 1 | Completed 1 |
Follow Nonverbal Communication: new trials by email Literature Review of Nonverbal Communication trials Research Report on Nonverbal Communication
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis Unresponsive to Optimal Symptomatic Treatment Masitinib, Placebo, Best Supportive Care - Indolent Systemic Mastocytosis | Phase 3 | Unknown | AB Science | 140 | 2020-07-01 | 2023-05-06 |
| Acupuncture in Infantile Colic - a Three Armed Randomized Multi Center Trial (ACU-COL) Acupuncture - Infantile Colic | Phase 2 / Phase 3 | Completed | Lund University | 147 | 2013-01-01 | 2016-06-28 |
| Lactobacillus Reuteri for the Treatment of Infantile Colic: Lactobacillus reuteri (DSM 17938) - Infantile Colic, Crying | Phase 3 | Completed | Medical University of Warsaw | 80 | 2009-12-01 | 2012-06-05 |
| Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis Masitinib, Placebo, Best Supportive Care - Indolent Systemic Mastocytosis | Phase 3 | Completed | AB Science | 135 | 2008-12-01 | 2019-12-03 |
| Gabapentin for the Treatment of Hot Flashes in Menopausal Women gabapentin - Hot Flashes, Menopause | Phase 3 | Completed | North Toronto Primary Care Research Network | 200 | 2004-03-01 | 2011-05-23 |
| Safety and Efficacy of AVP-923 for Pseudobulbar Affect in Multiple Sclerosis Patients AVP-923 - Multiple Sclerosis | Phase 3 | Completed | Avanir Pharmaceuticals | 96 | 2002-12-01 | 2016-07-14 |
Blushing (3) · Crying (3) · Colic (2) · Mastocytosis (2) · Mastocytosis, Systemic (2) · Piebaldism (2) · Pruritus (2) · Hot Flashes (1) · Laughter (1) · Multiple Sclerosis (1)
Behavior (6) · Communication (6) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4) · Immune System Diseases (3) · Pathological Conditions, Signs and Symptoms (3) · Signs and Symptoms (3) · Albinism (2) · Amino Acid Metabolism, Inborn Errors (2) · Eye Diseases, Hereditary (2) · Genetic Diseases, Inborn (2) · Hypopigmentation (2) · Infant, Newborn, Diseases (2) · Mast Cell Activation Disorders (2) · Metabolic Diseases (2)
masitinib (2) · Acupuncture Therapy (1) · Gabapentin (1) · dextromethorphan - quinidine combination (1)
AB Science (2) · Avanir Pharmaceuticals (1) · Lund University (1) · Medical University of Warsaw (1) · North Toronto Primary Care Research Network (1)
France (2) · Poland (2) · United States (2) · Canada (1) · Germany (1) · Netherlands (1) · Romania (1) · Russia (1) · Sweden (1) · Ukraine (1) · United Kingdom (1)
Cristina Bulai Livideanu, MD, MSc (1) · Debra Butt, MSc MD CCFP (1) · Kajsa Landgren, PhD (1) · Olivier Lortholary, MD, PhD (1)
PMID 16634036, PMID 22981952, PMID 26370560, PMID 28069279, PMID 28093383, PMID 32375501, PMID 36048877
2016 (1)